![]() |
|
|
Vol. 289, Issue 1, 511-520, April 1999
Departments of
Pharmacology and Therapeutics (L.P.D.B., J.L.M.,
B.K.P.) and
Chemistry (P.M.O.), University of Liverpool, Liverpool,
United Kingdom
Ro 42-1611 (arteflene) is a synthetic endoperoxide antimalarial. The
antimalarial activity of endoperoxides is attributed to
iron(II)-mediated generation of carbon-centered radicals. An
,
-unsaturated ketone (enone; 4-[2',4'
bis(trifluoromethyl)phenyl]-3-buten-2-one), obtained from arteflene by
reaction with iron(II), was identified previously as the stable product
of a reaction that, by inference, also yields a cyclohexyl
radical. The activation of arteflene in vivo has been
characterized with particular reference to enone formation.
[14C]Arteflene (35 µmol/kg) was given i.v. to
anesthetized and cannulated male rats: 42.2 ± 7.0% (mean ± S.D., n = 7) of the radiolabel was recovered in
bile over 5 h. In the majority of rats, the principal biliary
metabolites were 8-hydroxyarteflene glucuronide (14.2 ± 3.9%
dose, 0-3 h) and the cis and trans
isomers of the enone (13.5 ± 4.6% dose, 0-3 h). In conscious
rats, 15.3 ± 1.6% (mean ± S.D., n = 8)
of the radiolabel was recovered in urine over 24 h. The principal
urinary metabolite appeared to be a glycine conjugate of a derivative
of the enone. Biliary excretion of the glucuronide, but not of the
enones, was inhibited by ketoconazole. 8-Hydroxyarteflene was formed
extensively by rat and human liver microsomes but no enone was found.
Bioactivation is a major pathway of arteflene's metabolism in the rat.
Although the mechanism of in vivo bioactivation is unclear, the
reaction is not catalyzed by microsomal cytochrome P-450 enzymes.
This article has been cited by other articles:
![]() |
J. L. Maggs, L. P. D. Bishop, G. Edwards, P. M. O'Neill, S. A. Ward, P. A. Winstanley, and B. K. Park Biliary Metabolites of beta -Artemether in Rats: Biotransformations of an Antimalarial Endoperoxide Drug Metab. Dispos., February 1, 2000; 28(2): 209 - 217. [Abstract] [Full Text] |
||||